Canada announces accelerated delivery of COVID-19 paediatric vaccine pending regulatory authorization

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Canada announces accelerated delivery of COVID-19 paediatric vaccine pending regulatory authorization

Canada NewsWire

GATINEAU, QC, Oct. 21, 2021 /CNW/ - Throughout the pandemic, the Government of Canada has worked closely with vaccine manufacturers to negotiate the delivery of vaccines to Canada as quickly as possible.

On October 18, 2021, Pfizer submitted an application to Health Canada for regulatory review of the Pfizer-BioNTech COVID-19 vaccine COMIRNATY for children aged 5-11. This is an important step toward providing additional protection for our young Canadians.

The Government of Canada and Pfizer have agreed to an accelerated delivery schedule of this vaccine, pending regulatory authorization. Specifically, Pfizer and BioNTech have shared that deliveries of 2.9 million doses will begin shortly after regulatory authorization so that Canada receives enough doses to administer a first shot for all eligible children.

The Government of Canada will continue to closely monitor the evolution of COVID-19 vaccines and work with vaccine suppliers to access new formulations as quickly as possible, so we can finish the fight against COVID-19.

Quick facts

  • In April 2021, the Government of Canada signed an agreement with Pfizer for future supply of the Pfizer-BioNTech COVID-19 vaccine. The agreement provides flexibility to procure future COVID-19 vaccine formulations from Pfizer, such as those to protect against variants of concern and vaccines developed for children.
  • To date, Canada has received a total of more than 74 million doses of COVID-19 vaccine from Pfizer, Moderna and AstraZeneca.
  • More than 81% of eligible Canadians 12 years and older are now fully vaccinated, and more than 87% have received at least one dose of COVID-19 vaccine.
  • According to StatsCan data, as of July 1, 2021, there are 2,879,112 children age 5-11 in Canada.

Associated links

 Follow us on Twitter
 Follow us on Facebook

SOURCE Public Services and Procurement Canada

Cision View original content:

Copyright CNW Group 2021

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).